Rongtong Dictionary · Formula

Erchen Decoction: Origins, the Logic of Drying Damp and Transforming Phlegm, the Wendan Lineage, and Modern Metabolic Research

Published and reviewed 2026-07-09

Erchen (Two Matured Ingredients) Decoction comes from the Song-dynasty Taiping Huimin Heji Jufang and is the foundational formula for 'drying damp and transforming phlegm, regulating qi and harmonizing the middle,' honored as the 'general formula for dispelling phlegm.' Its name 'two matured' captures that pinellia and tangerine peel are 'best when aged' — the longer stored, the less their acrid dryness. Built from pinellia, tangerine peel, poria, and licorice with ginger and mume, it treats the 'damp-phlegm pattern,' its thinking traceable to Zhang Zhongjing's Xiao Banxia decoction. It is both a model of the phlegm-treating rule ('treat phlegm by first treating qi; the spleen is the source that generates phlegm') and the mother of many phlegm formulas such as Wendan, Daotan, and Liujunzi; modern research re-reads its 'phlegm-transforming' through lipid metabolism and oxidative stress, though a 'damp-phlegm pattern' remains a traditional construct, not a modern diagnosis such as hyperlipidemia.

Origin: the name 'two matured' and the Xiao Banxia roots

Erchen Decoction comes from the Song government formulary Taiping Huimin Heji Jufang (vol. 4) and is the foundational formula for the 'damp-phlegm pattern,' the later 'general formula for dispelling phlegm,' from which many qi-regulating, phlegm-transforming formulas descend. The classical indication is 'phlegm-rheum disorders, with nausea and vomiting, dizziness and palpitations, epigastric discomfort, alternating chills and fever, or spleen-stomach disharmony from eating raw and cold.'

The name 'two matured' is meaningful: pinellia and tangerine peel (or red tangerine peel) are both 'best when aged' — the longer stored, the less their acrid, drying vigor, so they transform phlegm without excessive dryness, hence 'two matured.' Its thinking traces to Zhang Zhongjing's Xiao Banxia decoction (pinellia and ginger) and Xiao Banxia plus Poria decoction in the Jinkui Yaolue, a 'contemporary-formula' development of classical-formula thought. The original composition is pinellia (washed seven times) and tangerine peel five liang each, poria three liang, and honey-fried licorice one-and-a-half liang, decocted with seven slices of ginger and one mume fruit. This page identifies the entity only and offers no dose conversion or preparation procedure.

Composition: a formula that demonstrates the phlegm-treating rule

Four main herbs with two guiding agents: pinellia (Pinelliae Rhizoma, sovereign), tangerine peel (Citri Reticulatae Pericarpium, minister), poria (Poria, assistant), and honey-fried licorice (Glycyrrhizae Radix, assistant-envoy), with fresh ginger (Zingiberis Rhizoma Recens) and mume (Mume Fructus) as guides.

The textbook reading embodies the phlegm-treating rule: pinellia, acrid, warm, and drying, excels at drying damp and transforming phlegm and at downbearing counterflow to harmonize the stomach and stop vomiting, striking at the phlegm-damp core as sovereign; tangerine peel regulates qi and moves stagnation while drying damp as minister — pinellia and tangerine peel in equal dose both reinforce each other's phlegm-transforming power and embody 'treat phlegm by first treating qi; when qi moves, phlegm dissolves.' Poria fortifies the spleen and percolates damp as assistant, 'percolating damp to aid phlegm-transformation and fortifying the spleen to cut off the source that generates phlegm' — matching 'the spleen is the source that generates phlegm.' Ginger both restrains pinellia's toxicity and aids phlegm-transformation and anti-emesis; a little mume astringes the lung and, with pinellia and tangerine peel, gives 'astringing within dispersing' so phlegm is dispelled without harming the upright; honey-fried licorice fortifies the spleen and harmonizes as assistant-envoy. The whole tends both branch and root — drying damp and regulating qi to dispel existing phlegm, and fortifying the spleen and percolating damp to cut off its source. Fang Guang's Danxi Xinfa Fuyu praised it as 'complete in substance and function, exhausting both branch and root,' warning that 'people, seeing only pinellia's dryness, replace it with other drugs, quite losing the formula's intent.'

Pattern, not disease: 'damp-phlegm' is not hyperlipidemia or another modern diagnosis

The textbook mechanism is 'damp-phlegm.' Damp-phlegm forms mostly when the spleen fails to transport and raw, cold food lets damp gather into phlegm. 'The spleen is the source that generates phlegm; the lung is the vessel that stores it,' so damp-phlegm invading the lung brings cough with copious white, easily expectorated phlegm; phlegm obstructing qi and disrupting stomach downbearing brings epigastric fullness, nausea, and vomiting; phlegm-turbidity blocking clear yang brings dizziness and palpitations; the spleen trapped by damp brings heavy limbs; a white slippery coating and slippery pulse complete the picture. The method is 'dry damp, transform phlegm, regulate qi, and harmonize the middle.'

Here 'phlegm' and 'damp-phlegm' are traditional functional constructs. It must be clarified: TCM 'phlegm' distinguishes 'substantial phlegm' (expectorated) from 'insubstantial phlegm' (dizziness, fullness, lumps attributed to phlegm-damp), a holistic account of a broad class of functional states, emphatically not a synonym for any single modern diagnosis. Modern research often applies the formula and its modifications to hyperlipidemia, fatty liver, and obesity 'phlegm-damp' populations, easily breeding the misreading 'phlegm-damp = high lipids/metabolic disease.' In fact, 'damp-phlegm pattern' and hyperlipidemia belong to different classification systems, the qualifier 'belonging to phlegm-damp' is crucial, and one cannot use the formula whenever lipids are high.

Historical development: the large family of the 'general phlegm formula'

The formula's stature comes from its role as the mother of the phlegm-transforming formulas. Adding arisaema and immature bitter orange yields Daotan Decoction (stronger drying-damp phlegm-transformation for stubborn, congealed phlegm); Daotan with bamboo shavings, bitter orange, and sour jujube yields the Wendan Decoction line (regulate qi, transform phlegm, harmonize stomach and gallbladder, for gallbladder-stomach disharmony with phlegm-heat, vexation, insomnia, and fright palpitations); Sijunzi with pinellia and tangerine peel — or Erchen with ginseng and atractylodes — yields Liujunzi Decoction (boost qi, fortify spleen, transform phlegm, for spleen-deficiency phlegm-damp); removing ginger and mume and adding sandalwood and amomum yields Xiangsha Erchen; adding apricot kernel and white mustard seed yields Liu'an Jian.

In short, wherever 'damp-phlegm disorders' occur, Erchen serves as the base to 'modify and treat.' This 'one formula as core, modified into a system' evolution makes Erchen the pivot for understanding the whole phlegm-dispelling method. It is now widely used across respiratory, digestive, and metabolic conditions belonging to phlegm-damp, and its modifications appear in some modern formulations. However modified, its core mechanism target — 'dry damp, transform phlegm, regulate qi, harmonize the middle' — and the 'best when aged' spirit remain unchanged.

Active constituents: from pinellia alkaloids to lipid-metabolism exploration

In modern terms, the material basis decomposes into each herb's actives: pinellia contains alkaloids, organic acids, phenylpropanoids, and volatile oils (pharmacology reports anti-inflammatory, anti-emetic, antibacterial, and lipid-regulating effects), tangerine peel contains hesperidin and other flavonoids, poria contains polysaccharides and triterpenes, and licorice contains glycyrrhizic acid and flavonoids. Studies note that pinellia and tangerine peel are a 'high-frequency drug pair' for hyperlipidemia, often used together to regulate lipid metabolism.

On mechanism, a review (PMC11598526) summarizes possible pathways for hyperlipidemia including lipid regulation (pinellia's phytosterols competitively inhibiting cholesterol absorption and potentiating the PPARγ pathway), reduction of oxidative stress (raising antioxidant enzymes such as SOD and GSH), and anti-inflammation; animal work (PMID 26504476) shows prevention of high-fat-diet-induced metabolic disorders in C57BL/6 mice, and network-pharmacology studies sketch a 'multi-component, multi-target' lipid-regulating hypothesis. The caveat: these are largely in-vitro, animal, and computational — mechanistic exploration, and the modern material basis of 'phlegm-transformation' cannot be equated with proven efficacy in human disease.

Evidence: what hyperlipidemia research shows

Erchen has considerable metabolic research (especially hyperlipidemia) that needs careful reading. On clinical evidence, a systematic-review/meta-analysis protocol (PMID 33080674) assesses the formula for hyperlipidemia; notably, its included clinical studies mostly used 'Erchen or modified Erchen,' often combined with lipid-regulating Western drugs such as statins and fibrates (for example, clinical observation of 'modified Erchen plus atorvastatin' for phlegm-turbidity hyperlipidemia), with control groups on conventional treatment (placebo, statins, or fibrates).

How to state it? First, many positive signals come from 'modified formula plus statin' scenarios, and cannot be extrapolated to 'the canonical formula alone lowers lipids' or 'can replace statins.' Second, included studies are mostly Chinese-language, predominantly modified formulas, with variable methodological quality. Third, animal 'prevention of metabolic disorders' cannot be directly extrapolated to humans. The defensible statement is that, mostly as modified formulas and often as combination therapy, it showed a signal of improving some measures in phlegm-damp metabolic populations, with variable evidence quality needing high-quality RCT confirmation — not that Erchen is proven to treat hyperlipidemia. Standard dyslipidemia management should still follow modern medicine.

Quality standards, patent medicines, and the Western-drug context

Pinellia, tangerine peel, poria, licorice, ginger, and mume are all Chinese Pharmacopoeia (2020) materials (tangerine peel by hesperidin, licorice by glycyrrhizic acid). Notably, pinellia is a 'toxic medicinal' requiring proper processing (fa-banxia, jiang-banxia, qing-banxia); raw pinellia is markedly toxic, and the Pharmacopoeia strictly regulates its processing and use. The market offers Erchen Pill and many phlegm-transforming patent medicines built on the Erchen base; same-named forms and modified formulas differ markedly in ratio and are not equivalent.

As contextual overlap (relationship only, not an efficacy comparison): the formula's modern research settings (damp-phlegm cough, copious phlegm, metabolic disorders) may be adjacent to Western-drug categories such as expectorants/mucolytics, anti-emetics, and lipid regulators (statins/fibrates) — as noted, its metabolic research often combines with statins. This is adjacency of application only, never equivalence of constituents or efficacy. Licorice constituents interact with antihypertensive, diuretic, and corticosteroid drugs and may affect blood pressure and electrolytes at high prolonged doses, and pinellia's interactions and toxicity especially require professional oversight.

Safety boundaries: pinellia's toxicity and differentiating 'phlegm'

The core of Erchen's safety is pinellia. Pinellia is a toxic medicinal whose raw form is markedly toxic (strongly irritating the mucosa of the mouth, throat, and digestive tract) and must be properly processed and used under professional guidance; traditionally it is among the 'eighteen incompatibilities,' antagonistic to aconite, and should not be combined with it. The formula is also warm and drying, so dry-phlegm, phlegm-heat, yin-deficiency dry cough, and hemoptysis are unsuited or need caution (Fang Guang warned against replacing pinellia over its dryness, and equally a warm-drying formula must not be misused in dry-heat patterns); pregnant women must use pinellia formulas with special caution.

On the boundary of use: cough with phlegm, dizziness, nausea and vomiting, and dyslipidemia all have many causes, and persistent or severe cases should first be worked up medically (chronic cough excluding infection, asthma, and lung disease; dizziness excluding otogenic and cardiocerebrovascular disease) rather than self-treated long-term with 'phlegm-transformation.' Dyslipidemia management should follow modern medicine. Erchen is an excellent model for the wisdom of 'treating phlegm,' but it contains a toxic medicinal and 'phlegm' differentiation is quite specialized, so its clinical use belongs to professional differentiation and pharmacist review.

A checklist for reading any formula article

1. Composition and preparation: does a stated effect come from Erchen itself, or from Daotan, Wendan, Liujunzi, or modified Erchen? Which processed form of pinellia is used?
2. Pattern versus disease: has 'damp-phlegm pattern' been equated directly with hyperlipidemia or fatty liver, and has 'substantial' been confused with 'insubstantial' phlegm?
3. Evidence tier and scenario: is the positive result 'canonical monotherapy' or 'modified formula plus statin,' and human research or animal/network-pharmacology work — with what quality?
4. Safety and interactions: does it address pinellia's toxicity and processing requirement, the aconite incompatibility, the unsuitability of a warm-drying formula in dry-heat/yin-deficiency, and licorice interactions?
5. Dose and procedure: responsible education identifies the entity and stops short of individual dosing and modifications — formulas with toxic medicinals especially require physician and pharmacist oversight.

Educational and academic reference only. It does not provide a diagnosis, prescription, dosage, or treatment recommendation. The pinellia in this formula is a toxic medicinal requiring proper processing and professional guidance and is traditionally antagonistic to aconite; the formula is warm and drying and unsuited to dry-heat/yin-deficiency patterns. Cough with phlegm, dizziness, or dyslipidemia should first be medically evaluated for cause; consult a licensed physician and pharmacist for any prescription.